1. Nakae D, Kishida H, Tsujiuchi T, Denda A, Kusuoka O, Tsutsumi M, Kotake Y, Hensley KL, Floyd RA, Konishi Y: PhenylN-tert-butylnitrone inhibition of hepatocellular carcinoma induction in rats fed a choline-deficient, t.-amino acid-defined diet. FASEB J, 2002 (submitted)
2. Nakae D, Kishida H, Enami T, Tsujiuchi T, Denda A, Tsutsumi M, Kotake Y, Hensley KL, Floyd RA, Konishi Y: Effects of phenylNtert-butyl nitrone and its derivatives on the early phase of hepatocarcinogenesis. FASEB J, 2002 (submitted)
3. Hensley K, Pye QN, Maidt ML, Stewart CA, Robinson KA, Jaffrey F, Floyd RA: Interaction of a-phenyl-N-tert-butyl nitrone and alternative electron acceptors with complex I indicates a substrate reduction site upstream from the rotenone binding site. J Neurochem 71: 2549–2557, 1998
4. Bostick RM, Potter JD, McKenzie DR, Sellers TA, Kushi LH, Steinmetz KA, Folsom AR: Reduced risk of colon cancer with high intake of vitamin E: The Iowa women’s health study. Cancer Res 53: 4230–4237, 1993
5. Hoeinonen OP, Albanes D, Virtamo J, Taylor PR, Huttunen JK, Hartman AM, Haapakoski J, Malila N, Rautalahti M, Ripatti S, Maenpaa H, Teerenhovi L, Koss L, Virolainen M, Edwards BK: Prostrate cancer and supplementation with a-tocopherol and 3-carotene: Incidence and mortality in a controlled trial. J Nat Cancer Inst 90: 440–446, 1998